Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Scientists from the University of the Philippines Diliman-College of Science conducted the first detailed microbial genomic study of an submarine groundwater discharge (SGD) site in the country, in ...

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's DiseaseNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron bids for 23andMe for a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

The truth is clear: Animal models aren’t just helpful; they’re irreplaceable. They remain central to understanding the ...

Mutant androgen receptor (mAR) levels, a proposed biomarker for SBMA, were assessed via muscle biopsies. Nuclear mAR levels were reduced by more than 50% in 53% of AJ201-treated patients, compared to ...

Blake Webb shares trends in automation and microfluidics that are reshaping medical diagnostics and laboratory processes.

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for hospitals, and slash research.